Barcelona BioMed Conference: Drosophila as a model in cancer
15 – 17 Jun 2015
Cancer is a multi-hit process involving mutations in oncogenes and tumour suppressors, as well as interactions between the tumour cells and the surrounding normal tissue.
The fruit fly, Drosophila, is an excellent, genetically-tractable system for modelling the development of cancer, due to the conservation of signalling pathways, cell proliferation and survival genes between fly and humans. Drosophila also presents an excellent system to study the importance of stem cells, which have pluripotent potential, in the development of cancer.
This conference presents a forum for the discussion of cutting-edge models of tumourigenesis in Drosophila and their use in high-throughput screening of small molecule inhibitors that can be developed to combat human cancer.
Organizers: Cayetano González and Marco Milán, IRB Barcelona (Barcelona, Spain)
Organised by the Institute for Research in Biomedicine (IRB Barcelona) with the collaboration of the BBVA Foundation.
Registration deadline: April 15, 2015
There is no registration fee for this conference, but the number of participants is limited.
Participants are invited to submit abstracts, a number of which will be selected for short talk and poster presentations. Abstracts should include a title, authors, affiliations, summary (max 250 words) and references.
The BARCELONA BIOMED CONFERENCE on Drosophila as a model in cancer will be hosted by the Institut d’Estudis Catalans (IEC) in the heart of downtown Barcelona. Talks will take place in the Sala Prat de Riba.
Institut d’Estudis Catalans
C. del Carme, 47